Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Astri Therapeutics Inc
(NQ:
ATXS
)
9.085
-0.085 (-0.93%)
Streaming Delayed Price
Updated: 2:53 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
811,637
Open
9.180
Bid (Size)
9.080 (9)
Ask (Size)
9.090 (4)
Prev. Close
9.170
Today's Range
8.970 - 9.460
52wk Range
4.260 - 16.90
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Astria Therapeutics Appoints Sunil Agarwal to Its Board of Directors
April 09, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 03, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Performance
YTD
+16.62%
+16.62%
1 Month
-32.85%
-32.85%
3 Month
-7.77%
-7.77%
6 Month
+92.89%
+92.89%
1 Year
-22.55%
-22.55%
More News
Read More
Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAE
March 25, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Earnings Preview For Astria Therapeutics
November 10, 2023
Via
Benzinga
Expert Ratings for Astria Therapeutics
October 13, 2023
Via
Benzinga
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 20, 2024
Via
Benzinga
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 05, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
ATXS Stock Earnings: Astria Therapeutics Misses EPS for Q4 2023
March 04, 2024
Via
InvestorPlace
Astria Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
March 04, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma & Immunology Annual Meeting
February 20, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics to Present at Upcoming Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 06, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 05, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics Announces Pricing of $125 Million Underwritten Offering
January 30, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 25, 2024
Via
Benzinga
$5.6M Bet On This Real Estate Stock? Check Out These 3 Stocks Insiders Are Buying
December 26, 2023
Via
Benzinga
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 04, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics to Present STAR-0215 Data at the 2023 World Allergy Congress
November 27, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics to Present at Upcoming 6th Annual Evercore ISI HealthCONx Conference
November 21, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics Reports Third Quarter Financial Results and Provides a Corporate Update
November 13, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics Presents New Phase 1a Data Confirming Potential for STAR-0125 to Prevent Hereditary Angioedema Attacks with Dosing 2 or 4 Times Per Year at the 2023 American College of Allergy, Asthma, and Immunology Annual Scientific Meeting
November 10, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics to Present at Upcoming Jefferies London Healthcare Conference
November 09, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Earnings Scheduled For November 13, 2023
November 13, 2023
Via
Benzinga
Astria Therapeutics to Present New STAR-0215 Data at the 2023 American College of Allergy, Asthma, And Immunology Annual Scientific Meeting
November 03, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 02, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Corporate Update on Monday, November 13th
October 30, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.